A detailed history of Eagle Asset Management Inc transactions in Arcellx, Inc. stock. As of the latest transaction made, Eagle Asset Management Inc holds 122,329 shares of ACLX stock, worth $11.1 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
122,329
Previous 190,604 35.82%
Holding current value
$11.1 Million
Previous $10.5 Million 2.89%
% of portfolio
0.06%
Previous 0.06%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$50.91 - $86.61 $3.48 Million - $5.91 Million
-68,275 Reduced 35.82%
122,329 $10.2 Million
Q2 2024

Aug 12, 2024

SELL
$49.74 - $66.98 $1.69 Million - $2.27 Million
-33,930 Reduced 15.11%
190,604 $10.5 Million
Q1 2024

May 09, 2024

BUY
$51.85 - $73.49 $11.6 Million - $16.5 Million
224,534 New
224,534 $15.6 Million

Others Institutions Holding ACLX

About Arcellx, Inc.


  • Ticker ACLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,819,200
  • Market Cap $3.96B
  • Description
  • Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...
More about ACLX
Track This Portfolio

Track Eagle Asset Management Inc Portfolio

Follow Eagle Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Asset Management Inc with notifications on news.